Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2011

01-12-2011 | Pancreatic Tumors

Distal Pancreatectomy Combined with Celiac Axis Resection: An Alternative Approach for Some Advanced Diatal Pancreatic Cancer

Authors: Xubo Wu, Ran Tao, Peng Chongpeng

Published in: Annals of Surgical Oncology | Special Issue 3/2011

Login to get access

Excerpt

We read the comments by Yang et al. with great interest. Extended radical resection for pancreatic cancer remains a controversial problem because of the complexity of the surgical procedure itself and lack of evidence of survival benefit. We applied this approach to treating the patients with pancreatic body/tail carcinoma involving celiac axis (CA) or common hepatic artery (CHA) only and expected to improve the quality of life and prolong the survival time. Sener et al. also noted that the best survival rates per stage were achieved after surgical resection.1 …
Literature
1.
Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg. 1999;189(1):1–7.PubMedCrossRef
2.
Al-Haddad M, Martin JK, Nguyen J, Pungpapong S, Raimondo M, Woodward T, et al. Vascular resection and reconstruction for pancreatic malignancy: a single center survival study. J Gastrointest Surg. 2007;11(9):1168–74.PubMedCrossRef
3.
Yekebas EF, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist YK, et al. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg. 2008;247(2):300–9.PubMedCrossRef
Metadata
Title
Distal Pancreatectomy Combined with Celiac Axis Resection: An Alternative Approach for Some Advanced Diatal Pancreatic Cancer
Authors
Xubo Wu
Ran Tao
Peng Chongpeng
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1380-x

Other articles of this Special Issue 3/2011

Annals of Surgical Oncology 3/2011 Go to the issue

Endocrine Tumors

Incidental Papillary Microcarcinoma of the Thyroid—Further Evidence of a Very Low Malignant Potential: A Retrospective Clinicopathologic Study with up to 30 Years of Follow-up

Erratum

Erratum to: Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer

Gynecologic Oncology

Let’s Think Twice Before Abandoning Fibrillar Oxidized Regenerated Cellulose

Gastrointestinal Oncology

Re: Aggressive Surgical Approach for Patients with T4 Gastric Carcinoma: Promise or Myth?

Breast Oncology

Anti-cytokeratin CAM5.2 (BD Biosciences) and CK8 Give No Remarkable Advantages to the Pancytokeratin Cocktail of Antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in Detecting Disseminated Tumor Cells in Biologic Subtypes of Stage I–III Breast Cancer Patients

Endocrine Tumors

In Reply: Surgeon-Performed Ultrasound and Prediction of Differentiated Thyroid Cancer